Sydney A Huffman, AA - Medicare Anesthesiologist Assistant in Cleveland, OH

Sydney A Huffman, AA is a medicare enrolled "Anesthesiologist Assistant" in Cleveland, Ohio. Her current practice location is 9500 Euclid Ave, Cleveland, Ohio. You can reach out to her office (for appointments etc.) via phone at (216) 444-2200.

Sydney A Huffman is licensed to practice in Ohio (license number 67.000445) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1275272635.

Contact Information

Sydney A Huffman, AA
9500 Euclid Ave,
Cleveland, OH 44195
(216) 444-2200
Not Available



Provider's Profile

Full NameSydney A Huffman
GenderFemale
SpecialityAnesthesiologist Assistant
Location9500 Euclid Ave, Cleveland, Ohio
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1275272635
  • Provider Enumeration Date: 06/02/2022
  • Last Update Date: 05/15/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0648659656
  • Enrollment ID: I20220622002128

Medical Identifiers

Medical identifiers for Sydney A Huffman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275272635NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367H00000XAnesthesiologist Assistant 67.000445 (Ohio)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sydney A Huffman allows following entities to bill medicare on her behalf.
Entity NameThe Cleveland Clinic Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679525919
PECOS PAC ID: 1850203555
Enrollment ID: O20031103000049

News Archive

Novel signal-processing tool enables unbiased, data-driven analysis of ultrasonic vocalizations

Vocalization plays a significant role in social communication across species such as speech by humans and song by birds. Male mice produce ultrasonic vocalizations in the presence of females and both sexes sing during friendly social encounters.

How India's lockdown has affected mental health

India's public landscape has transformed dramatically over the last couple of months, with the most prolonged lockdown that the present generation can remember. Declared on March 24, 2020, the lockdown ensured that hundreds of millions of people were effectively confined to home, except when they ventured out, armed with a self-attested affidavit, to stock up on essentials.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

Read more Medical News

› Verified 8 days ago

Entity NameUniversity Primary Care Practices Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003935339
PECOS PAC ID: 3072417534
Enrollment ID: O20031125000767

News Archive

Novel signal-processing tool enables unbiased, data-driven analysis of ultrasonic vocalizations

Vocalization plays a significant role in social communication across species such as speech by humans and song by birds. Male mice produce ultrasonic vocalizations in the presence of females and both sexes sing during friendly social encounters.

How India's lockdown has affected mental health

India's public landscape has transformed dramatically over the last couple of months, with the most prolonged lockdown that the present generation can remember. Declared on March 24, 2020, the lockdown ensured that hundreds of millions of people were effectively confined to home, except when they ventured out, armed with a self-attested affidavit, to stock up on essentials.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

Read more Medical News

› Verified 8 days ago

Entity NameUniversity Hospitals Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669499414
PECOS PAC ID: 4789682493
Enrollment ID: O20061113000301

News Archive

Novel signal-processing tool enables unbiased, data-driven analysis of ultrasonic vocalizations

Vocalization plays a significant role in social communication across species such as speech by humans and song by birds. Male mice produce ultrasonic vocalizations in the presence of females and both sexes sing during friendly social encounters.

How India's lockdown has affected mental health

India's public landscape has transformed dramatically over the last couple of months, with the most prolonged lockdown that the present generation can remember. Declared on March 24, 2020, the lockdown ensured that hundreds of millions of people were effectively confined to home, except when they ventured out, armed with a self-attested affidavit, to stock up on essentials.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

Read more Medical News

› Verified 8 days ago

Entity NameOhio Anesthesia Group, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639348113
PECOS PAC ID: 9537222138
Enrollment ID: O20090108000069

News Archive

Novel signal-processing tool enables unbiased, data-driven analysis of ultrasonic vocalizations

Vocalization plays a significant role in social communication across species such as speech by humans and song by birds. Male mice produce ultrasonic vocalizations in the presence of females and both sexes sing during friendly social encounters.

How India's lockdown has affected mental health

India's public landscape has transformed dramatically over the last couple of months, with the most prolonged lockdown that the present generation can remember. Declared on March 24, 2020, the lockdown ensured that hundreds of millions of people were effectively confined to home, except when they ventured out, armed with a self-attested affidavit, to stock up on essentials.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sydney A Huffman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sydney A Huffman, AA
9500 Euclid Ave,
Cleveland, OH 44195-0001

Ph: (216) 444-2200
Sydney A Huffman, AA
9500 Euclid Ave,
Cleveland, OH 44195

Ph: (216) 444-2200

News Archive

Novel signal-processing tool enables unbiased, data-driven analysis of ultrasonic vocalizations

Vocalization plays a significant role in social communication across species such as speech by humans and song by birds. Male mice produce ultrasonic vocalizations in the presence of females and both sexes sing during friendly social encounters.

How India's lockdown has affected mental health

India's public landscape has transformed dramatically over the last couple of months, with the most prolonged lockdown that the present generation can remember. Declared on March 24, 2020, the lockdown ensured that hundreds of millions of people were effectively confined to home, except when they ventured out, armed with a self-attested affidavit, to stock up on essentials.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

Read more News

› Verified 8 days ago


Anesthesiologist Assistant Nurses in Cleveland, OH

Shannon Kelly, AA-C
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109
Phone: 216-778-7800    
Olivia Kehoe, CAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 11100 Euclid Ave, Cleveland, OH 44106
Phone: 216-844-1000    
Brian Michael Wheatley,
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109
Phone: 216-778-7800    
Nicole M Moses, CAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109
Phone: 216-778-7800    
Michael Marcotte, CAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109
Phone: 216-778-7800    
Thomas Bruno, AA
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 11100 Euclid Ave, Cleveland, OH 44106
Phone: 216-844-7330    
Gregory G Kychun, AA
Anesthesiologist Assistant
Medicare: Not Enrolled in Medicare
Practice Location: 11100 Euclid Ave, Cleveland, OH 44106
Phone: 216-844-7330    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.